PLUR
Pluri Inc.
NASDAQ · Healthcare · Biotechnology · IL
$1.34
−2.03%Next report
Analyst consensus
- Next report date
- Sep 23, 2026
- EPS estimate
- -$0.66
- Revenue estimate
- $655.0K
Latest reported
- Last report date
- May 14, 2026
- EPS actual
- -$0.55
- EPS estimate
- -$0.66
- Revenue actual
- $167.0K
- Revenue estimate
- $655.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -70.9%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 23, 2026